CROS NT Joins PHUSE Eu 2021

We are pleased to announce that this year we will be joining PHUSE EU Connect 2021 as delegates and sponsors of the hands-on workshop “Clinical Trial Safety Analyses – Common Pitfalls and FAQ” conducted by Eli Lilly. 

Event information:

  • Event format: Hybrid
  • Date: 15 – 19 November 2021
  • Registration & agenda: available on the official website of PHUSE EU Connect
  • Our attendees:
    • Caroline Gray – Director of Statistical Programming
    • Catriona Mc Glade – Associate Director, Statistical Programming
    • Jorge Goncalves – Associate Director, Statistical Programming
    • Daniel Chapple – VP of Business Development
    • Valerio Calvanese – Business Development Manager

 About PHUSE EU Connect:

The Connect creates a space for global professionals from across the industry to unite, explore and train through its trademark inspirational content and networking opportunities. As a transition back to physical events, the EU Connect will be a hybrid event, with Monday and Tuesday taking place in person in London, UK (limited capacity) and Thursday and Friday remaining virtual. To enhance the audience experience, a selection of speakers will join PHUSE in London to present in person to both the live audience and virtual attendees as part of the daily broadcast. All sessions will also be available to watch on-demand on the PHUSE Engagement Hub.

About CROS NT

CROS NT is part of Alira Health, a leading international healthcare, and life sciences advisory services firm.

We are a global team of passionate specialists delivering innovative, high-quality, tailored biometrics solutions. We support you in developing therapeutics for patients in a smarter manner by facilitating digital technologies, data integration, standardisation, visualisation and analytics, and data oversight.

As biometrics specialists we have made a difference to over 500 projects, by minimising risk, increasing insight, and maximising outcomes for patients. Our core expertise spans clinical data management, biostatistics, and statistical programming, with our work on centralised biometrics gaining recognition industry-wide.